Acupuncture Delivery In The Clinical Decision Unit (CDU) For The Management Of Pain, Nausea, And Other Symptoms
The overall goal of this research is to improve the management of distressing symptoms, specifically nausea and pain, in cancer patients within the acute care setting of the CDU at MD Anderson.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
Primary Objectives and Endpoints:
Determine the feasibility of an operational protocol of providing acupuncture treatment for nausea and/or pain in the CDU at MD Anderson Cancer Center. Feasibility will be assessed by the proportion of eligible patients who consent to and receive at least one acupuncture treatment. Successful feasibility will be defined as at least 50% of the eligible patients approached consenting and receiving at least one acupuncture session.
Secondary Objectives and Endpoints:
- Examine changes in pain and nausea reported in cancer patients after a single session of acupuncture in the CDU. Preliminary efficacy will be evaluated by having patients complete the ESAS symptom severity before and after each acupuncture session.
- Examine changes in other symptoms assessed on the ESAS after a single session of acupuncture in the CDU. Individual items will be explored as well as global (all symptoms), physical (drowsiness, nausea, pain, shortness of breath, poor appetite, fatigue), and psychological distress (anxiety and depression) subscales.
- Explore the safety profile of providing acupuncture in the CDU. Data will be collected to systematically document and grade any adverse events related to the acupuncture treatment according to the Common Terminology Criteria for Adverse Events (CTCAE) v6.0.
- Explore the patient experience with acupuncture in the CDU. Patients will be asked about their satisfaction with acupuncture, whether they believe it was helpful to reduce their symptoms, if they would use the service again, and if they would recommend acupuncture to others in the CDU. An additional open-ended question will allow patients to make recommendations for future program or service offerings. Satisfaction will be administered to all study participants after each treatment.
- Explore the CDU staff experience with acupuncture in the CDU. The primary clinician assigned to the patient will be asked about their satisfaction with the use of acupuncture for the patient. They will be asked about the logistics of delivering acupuncture and if they perceive any benefit for the patient from before to after in terms of pain, nausea, or anxiety.
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前:Maxine De La Cruz, MD
- 電話番号:713-563-4419
- メール:mgde@mdanderson.org
研究場所
-
-
Texas
-
Houston、Texas、アメリカ、77030
- UT MD Anderson
-
コンタクト:
- Maxine De La Cruz, MD
- 電話番号:713-563-4419
- メール:mgde@mdanderson.org
-
主任研究者:
- Maxine De La Cruz, MD
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Adult patients (aged ≥18 years)
- Presenting with a primary complaint of nausea and/or pain
- ESAS nausea and/or pain score of at least 2
- Admitted to the CDU for observation and management of nausea and/or pain.
Exclusion Criteria:
An individual who meets any of the following criteria will be excluded from participation in this study:
- History of a bleeding disorder
- Coagulation profile with an INR > 2.0 and/or PTT > 90 seconds
- Initiation of anticoagulation for venous thrombosis within the last 24 hours or not yet at a therapeutic dose
- Evidence of bowel obstruction on imaging
- Platelet count < 25,000/uL
- Absolute Neutrophil Count (ANC) < 1.0 K/uL
- Delirium or cognitive impairment in the opinion of the primary CDU physician that limits the ability to follow instructions or provide informed consent.
- Pregnant patients for whom the treating physician or acupuncturist determines acupuncture is not clinically appropriate.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:支持療法
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:Treatment with Acupuncture
Participants to recruit from are those participants who are admitted into the CDU at UT MD Anderson. |
Treatment will be administered at the participant's bedside in CDU. Needles will remain in place for 20-25 minutes with each treatment. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Safety and Adverse Events (AEs)
時間枠:Through study completion; an average of 1 year
|
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 6.0 |
Through study completion; an average of 1 year
|
協力者と研究者
捜査官
捜査官
- 主任研究者:Maxine De La Cruz, MD、UT MD Anderson
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (推定)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
その他の研究ID番号
- 2026-0644
- NCI-2026-08619 (その他の識別子:NCI-CTRP Clinical Trials Registry)
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。